129 related articles for article (PubMed ID: 37028695)
21. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
[TBL] [Abstract][Full Text] [Related]
22. Orbital decompression for thyroid eye disease: surgical treatment outcomes in endocrinological assessment.
Jurek-Matusiak O; Brożek-Mądry E; Jastrzębska H; Krzeski A
Endokrynol Pol; 2021; 72(6):609-617. PubMed ID: 34647604
[TBL] [Abstract][Full Text] [Related]
23. Management of patients in a combined thyroid eye clinic in secondary care.
Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
[TBL] [Abstract][Full Text] [Related]
24. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss.
Park J; Baek S
Acta Ophthalmol; 2019 Aug; 97(5):e800-e806. PubMed ID: 30593716
[TBL] [Abstract][Full Text] [Related]
25. The prediction of pouch of Douglas obliteration using offline analysis of the transvaginal ultrasound 'sliding sign' technique: inter- and intra-observer reproducibility.
Reid S; Lu C; Casikar I; Mein B; Magotti R; Ludlow J; Benzie R; Condous G
Hum Reprod; 2013 May; 28(5):1237-46. PubMed ID: 23482338
[TBL] [Abstract][Full Text] [Related]
26. Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies.
Winn BJ; Kersten RC
Ophthalmology; 2021 Nov; 128(11):1627-1651. PubMed ID: 33930408
[TBL] [Abstract][Full Text] [Related]
27. Thermal Imaging of the Ocular Surface in Thyroid Eye Disease: A Comparison between Active, Inactive and Healthy Eyes.
Dave TV; Patodi P; Richhariya A; Dave VP
Curr Eye Res; 2021 Oct; 46(10):1482-1488. PubMed ID: 33745401
[No Abstract] [Full Text] [Related]
28. Functional and structural evaluation of the meibomian gland using a LipiView interferometer in thyroid eye disease.
Park J; Kim J; Lee H; Park M; Baek S
Can J Ophthalmol; 2018 Aug; 53(4):373-379. PubMed ID: 30119792
[TBL] [Abstract][Full Text] [Related]
29. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
30. Inter-observer and intra-observer agreement between embryologists during selection of a single Day 5 embryo for transfer: a multicenter study.
Storr A; Venetis CA; Cooke S; Kilani S; Ledger W
Hum Reprod; 2017 Feb; 32(2):307-314. PubMed ID: 28031323
[TBL] [Abstract][Full Text] [Related]
31. Bilateral versus unilateral thyroid eye disease.
Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
[TBL] [Abstract][Full Text] [Related]
32. Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
Kim JW; Woo YJ; Yoon JS
Endocr J; 2016 Dec; 63(12):1133-1140. PubMed ID: 27628269
[TBL] [Abstract][Full Text] [Related]
33. Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study.
Dolman PJ; Cahill K; Czyz CN; Douglas RS; Elner VM; Feldon S; Kazim M; Lucarelli M; Sivak-Collcott J; Stacey AW; Strianese D; Uddin J
Ophthalmology; 2012 Feb; 119(2):382-9. PubMed ID: 21959369
[TBL] [Abstract][Full Text] [Related]
34.
Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S;
Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769
[TBL] [Abstract][Full Text] [Related]
35. Phenotypes of Thyroid Eye Disease.
Uddin JM; Rubinstein T; Hamed-Azzam S
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S28-S33. PubMed ID: 29905636
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of pulsed intravenous methylprednisolone in early active thyroid eye disease.
Young SM; Lim AYN; Lang SS; Lee KO; Sundar G
Orbit; 2019 Oct; 38(5):362-369. PubMed ID: 30540214
[No Abstract] [Full Text] [Related]
37. Clinical profile of 80-year-old and older thyroid eye disease patients.
Levy N; Leiba H; Landau K; Zloto O; Huna-Baron R
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2727-2736. PubMed ID: 35338398
[TBL] [Abstract][Full Text] [Related]
38. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
39. Hypo vs. hyperthyroid eye disease: is there any difference?
Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
BMC Ophthalmol; 2023 Feb; 23(1):58. PubMed ID: 36765316
[TBL] [Abstract][Full Text] [Related]
40. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
